Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert J Harris

Showing results (11-20 of 82) with videos related to

Pageof 9
Sort By:
The American Journal of Pathology|January 27, 2007
Central role of protein kinase Cepsilon in constitutive activation of ERK1/2 and Rac1 in the malignant cells of hairy cell leukemiaJoseph R Slupsky, Aura S Kamiguti, Robert J Harris, et al.
Magnetic Resonance Imaging|April 19, 2005
A comparison of experimental and simulated propagators in porous media using confocal laser scanning microscopy, lattice Boltzmann hydrodynamic simulations and nuclear magnetic resonanceRobert J Harris, Andrew J Sederman, Michael D Mantle, et al.
Blood|July 19, 2003
High frequency of p53 dysfunction and low level of VH mutation in chronic lymphocytic leukemia patients using the VH3-21 gene segmentKe Lin, Sameer Manocha, Robert J Harris, et al.
Antimicrobial Agents and Chemotherapy|July 23, 2014
Synergy of silver nanoparticles and aztreonam against Pseudomonas aeruginosa PAO1 biofilmsMarc B Habash, Amber J Park, Emily C Vis, et al.
Blood|August 2, 2008
Effective dasatinib uptake may occur without human organic cation transporter 1 (hOCT1): implications for the treatment of imatinib-resistant chronic myeloid leukemiaAthina Giannoudis, Andrea Davies, Claire M Lucas, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|December 12, 2025
OMIP-119: A 36-Color Full-Spectrum Flow Cytometry Panel for Deep Immunophenotyping of Peripheral Blood and Ex Vivo Expanded Human T CellsRobert J Harris, Benjamin Arkle, Elizabeth Evans, et al.
Molecular Pharmaceutics|March 14, 2018
Multiple Linear Regression Modeling To Predict the Stability of Polymer-Drug Solid Dispersions: Comparison of the Effects of Polymers and Manufacturing Methods on Solid Dispersion StabilityGudrun A Fridgeirsdottir, Robert J Harris, Ian L Dryden, et al.
Blood|April 15, 2011
Cancerous inhibitor of PP2A (CIP2A) at diagnosis of chronic myeloid leukemia is a critical determinant of disease progressionClaire M Lucas, Robert J Harris, Athina Giannoudis, et al.
Cancer Research|October 17, 2008
Cell motility in chronic lymphocytic leukemia: defective Rap1 and alphaLbeta2 activation by chemokineKathleen J Till, Robert J Harris, Andrea Linford, et al.
British Journal of Haematology|January 14, 2010
BCR-ABL1 tyrosine kinase activity at diagnosis, as determined via the pCrkL/CrkL ratio, is predictive of clinical outcome in chronic myeloid leukaemiaClaire M Lucas, Robert J Harris, Athina Giannoudis, et al.
Pageof 9

Showing results (11-20 of 82) with videos related to

Sort By:
Pageof 9
The American Journal of Pathology|January 27, 2007
Central role of protein kinase Cepsilon in constitutive activation of ERK1/2 and Rac1 in the malignant cells of hairy cell leukemiaJoseph R Slupsky, Aura S Kamiguti, Robert J Harris, et al.
Magnetic Resonance Imaging|April 19, 2005
A comparison of experimental and simulated propagators in porous media using confocal laser scanning microscopy, lattice Boltzmann hydrodynamic simulations and nuclear magnetic resonanceRobert J Harris, Andrew J Sederman, Michael D Mantle, et al.
Blood|July 19, 2003
High frequency of p53 dysfunction and low level of VH mutation in chronic lymphocytic leukemia patients using the VH3-21 gene segmentKe Lin, Sameer Manocha, Robert J Harris, et al.
Antimicrobial Agents and Chemotherapy|July 23, 2014
Synergy of silver nanoparticles and aztreonam against Pseudomonas aeruginosa PAO1 biofilmsMarc B Habash, Amber J Park, Emily C Vis, et al.
Blood|August 2, 2008
Effective dasatinib uptake may occur without human organic cation transporter 1 (hOCT1): implications for the treatment of imatinib-resistant chronic myeloid leukemiaAthina Giannoudis, Andrea Davies, Claire M Lucas, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|December 12, 2025
OMIP-119: A 36-Color Full-Spectrum Flow Cytometry Panel for Deep Immunophenotyping of Peripheral Blood and Ex Vivo Expanded Human T CellsRobert J Harris, Benjamin Arkle, Elizabeth Evans, et al.
Molecular Pharmaceutics|March 14, 2018
Multiple Linear Regression Modeling To Predict the Stability of Polymer-Drug Solid Dispersions: Comparison of the Effects of Polymers and Manufacturing Methods on Solid Dispersion StabilityGudrun A Fridgeirsdottir, Robert J Harris, Ian L Dryden, et al.
Blood|April 15, 2011
Cancerous inhibitor of PP2A (CIP2A) at diagnosis of chronic myeloid leukemia is a critical determinant of disease progressionClaire M Lucas, Robert J Harris, Athina Giannoudis, et al.
Cancer Research|October 17, 2008
Cell motility in chronic lymphocytic leukemia: defective Rap1 and alphaLbeta2 activation by chemokineKathleen J Till, Robert J Harris, Andrea Linford, et al.
British Journal of Haematology|January 14, 2010
BCR-ABL1 tyrosine kinase activity at diagnosis, as determined via the pCrkL/CrkL ratio, is predictive of clinical outcome in chronic myeloid leukaemiaClaire M Lucas, Robert J Harris, Athina Giannoudis, et al.
Pageof 9